OpGen's brand, Ares Genetics, is at the forefront of revolutionizing the global fight against antimicrobial resistance (AMR). By developing DNA-based infectious disease services and solutions, Ares Genetics aims to transform the diagnosis, prevention, and treatment of AMR infections. Their cutting-edge approach combines next-generation sequencing (NGS) and artificial intelligence (AI) powered solutions to provide unprecedented insight into AMR.

Unlike traditional molecular assays, Ares Genetics' innovative solutions not only detect AMR markers but also provide information on their prevalence, diagnostic performance, and predict how pathogens will respond to therapy. Ares Genetics offers a comprehensive portfolio of services and solutions for outbreak surveillance, infection control, AMR prediction, and targeted antimicrobial therapy delivery. Their offerings include isolate sequencing services (ARES iss), genomic pathogen identification (ARES id), the comprehensive AMR surveillance panel (ARES asp), and the user-friendly bioinformatics and reporting hub powered by ARES db called ARES cloud.

ARES db is a comprehensive database of AMR biomarkers, providing valuable information on the diagnostic performance of AMR markers and enabling AI-powered prediction of phenotypic resistance directly from genome data. Join the fight against AMR with Ares Genetics and discover their revolutionary ARES products